$CTSH

Kerdman Alina sold $9K of CTSH

Kerdman Alina (SVP, Controller & CAO) sold 144 shares of COGNIZANT TECHNOLOGY SOLUTIONS CORP (CTSH) at $63.34 on 2026-08-31 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Kerdman Alina
Published Sep 2, 2026, 8:16 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Sep 2, 2026, 8:54 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$CTSH
Neutral
high confidence
Mentioned
$CTSH
Relevance
2/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$CTSHNeutralLow
01

Why it matters

The disclosed sale is small and pre‑planned, likely offering little actionable insight.

02

Market read

Minor insider sell with negligible market impact.

03

What to watch

Potential upcoming earnings or guidance that prompted the pre‑planned sale.

Relevance 2/10Novelty 4/10Timing: post‑market 2026‑08‑31

Background

Form 4 filings disclose insider transactions; traders monitor large sales for signals.

Company-level read

Ticker impact

$CTSHNeutralHigh confidence
Context

SVP Alina Kerdman sold 144 shares of Cognizant (CTSH) for $9,120 via a 10b5‑1 plan, reducing her holding to 848 shares.

Expected impact

No material price movement expected; at most a few basis‑point dip.

Evidence & confidence

The sale amount ($9k) is tiny relative to market cap; insider is not a top executive; 10b5‑1 plan suggests pre‑planned execution.

Market effects

No sector‑wide impact; typical insider activity in technology services.

Limited to U.S. equity market; no regional ripple.

Insignificant on a global scale.

Counterpoint

If the insider is reducing exposure ahead of a negative catalyst, the stock could face downside pressure.

Key entities

  • Cognizant Technology Solutions Corp

    US‑listed IT services firm (ticker CTSH).

  • Alina Kerdman

    SVP, Controller & CAO at Cognizant.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$CTSHMedAI 8/10

Cognizant's AI Gamble: What Nearshore Must Learn

Cognizant reported Q2 2026 revenue growth of 4.5%, down from Q2 2025, but beat peers and met guidance. Bookings fell 6% YoY. The company raised full-year EPS guidance to $5.70-$5.82, and its stock surged 41.81% in a month. Cognizant cited AI-led demand and partnerships with Google Cloud and Anthropic.

$CTSHMed

Anthropic Is Only Part of the Story. Cognizant Has a Much Bigger AI Plan.

Cognizant (CTSH) trades at a discount versus its historical valuation, with forward GAAP P/E of 8.31x and P/S of 0.97x. In Q2, it reported EPS $1.37 vs $1.38 expected, 4.5% revenue growth, and $459M free cash flow. Management guided Q3 growth 3.8%-5.3% YoY and FY EPS to $5.76 midpoint. Guggenheim cut its price target to $65 but kept a Buy; analysts’ mean target is $60.12.

$CTSHMedAI 8/10

Cognizant Technology Solutions Corporation Q2 2026 Earnings Call Summary

Cognizant Technology Solutions reported 4.1% year-over-year constant-currency revenue growth in Q2 2026, driven by North America and 12% growth in financial services. The company revised full-year revenue guidance to 4% to 5.5% growth and kept adjusted operating margin at 16% to 16.2%. It cited an $81M one-time India benefit, Project LEAP costs, and interest expense after a $1B Astreya-related draw.

$CTSHMed

Cognizant Earnings: Financial Services and North America Drive Resilient Performance

Morningstar’s stock note says Cognizant (CTSH) reported 4% Q2 constant-currency revenue growth, with operating margin steady at 16% and trailing 12-month bookings up 5%. It attributes results to North America and financial services, where growth was 12%. Morningstar keeps a $84 fair value estimate and 16.0%-16.2% operating margin guidance, while trimming full-year revenue growth outlook to 4.0%-5.5%.